Two Sigma Advisers
ARKG icon

Two Sigma Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Two Sigma Advisers’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-41,800
Closed -$1.07M – 2335
2024
Q3 		$1.07M Sell
41,800
-10,200
-20% -$260K ﹤0.01% 1380
2024
Q2 		$1.22M Sell
52,000
-75,300
-59% -$1.9M ﹤0.01% 1451
2024
Q1 		$3.66M Sell
127,300
-242,400
-66% -$7.29M 0.01% 919
2023
Q4 		$12.1M Buy
+369,700
New +$10.1M 0.03% 459
2023
Q2 		– Sell
-68,500
Closed -$2.06M – 2380
2023
Q1 		$2.06M Buy
+68,500
New +$2.12M 0.01% 1257
2022
Q3 		– Sell
-53,300
Closed -$1.68M – 2536
2022
Q2 		$1.68M Buy
+53,300
New +$1.86M ﹤0.01% 1306

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Two Sigma Advisers's ARKG Position: Q4 2024 in Review

Two Sigma Advisers sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 41,800 shares — an estimated $1.07M sold.

Two Sigma Advisers first reported a position in ARKG in Q2 2022 and held it in 6 quarters. The position peaked at $12.1M in Q4 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Two Sigma Advisers reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 41,800 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $1.07M.
  • Two Sigma Advisers first reported a position in ARK Genomic Revolution ETF in Q2 2022 and held it in 6 quarters.
  • Two Sigma Advisers's ARK Genomic Revolution ETF position peaked at $12.1M in Q4 2023.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.